DexCom (DXCM) Misses Q4 EPS by 17c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $74.40 +0.38%
Revenue Growth %: +11.2%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
LEDS, DSNY, SPRS, More
Revenue Growth %: +11.2%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
LEDS, DSNY, SPRS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.
GUIDANCE:
DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- ConAgra Brands (CAG) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY EPS Guidance
- Health Canada authorizes Dexcom G7 15 Day CGM for Canadian adults
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
